Genentech and City of Hope Sues Glaxo Group, Human Genome Sciences and Lonza Biologics

April 14, 2011

Genentech and City of Hope files suit against Glaxo Group, Human Genome Sciences, and Lonza Biologics over a patent related to methods of making antibody heavy and light chains having specificity for a desired antigen. 4/12, Central District of California, 2:2011cv03065.


Access to the full article is currently available to RPX members only. Please contact us if you need further information.



Related News

×
×

Thank you for your feedback

×
×